Similar articles

• Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.

  Ahmed MS, Jacques LC, Mahallawi W, Ferrara F, Temperton N, Upile N, Vaughan C, Sharma R, Beer H, Hoschler K, McNamara PS, Zhang Q. Ahmed MS, et al. Antiviral Res. 2015 Feb;114:106-12. doi: 10.1016/j.antiviral.2014.12.008. Epub 2014 Dec 13. Antiviral Res. 2015. PMID: 25513756
• [Serodiagnosis in the surveillance of the influenza virus circulation during the development of the pandemic caused by the A (H1N1)pdm09].

  Mukasheva E, Kolobukhina LV, Merkulova LV, Kisteneva LB, Zaplatnikov AL, Smolonogina TA, Desheva YA, Mikhaylova EV, Romanovskaya AV, Dubovitskaya NA, Burtseva EI. Mukasheva E, et al. Vopr Virusol. 2015;60(6):19-24. Vopr Virusol. 2015. PMID: 27024912 Russian.
• [Advances in the structure and function of pandemic A/H1N1/2009 influenza virus HA protein].

  Zhang WQ, Song SX, Wang TZ. Zhang WQ, et al. Bing Du Xue Bao. 2012 Jun;28(4):444-52. Bing Du Xue Bao. 2012. PMID: 22978172 Review. Chinese.
• Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.

  Mak GC, Choy PW, Lee WY, Wong AH, Ng KC, Lim W. Mak GC, et al. J Med Virol. 2010 Nov;82(11):1809-15. doi: 10.1002/jmv.21895. J Med Virol. 2010. PMID: 20872705
• Treating the host response: an alternative way to manage Ebola in Africa and the next influenza pandemic.

  Fedson DS. Fedson DS. J Glob Health. 2019 Jun;9(1):010322. doi: 10.7189/jogh.09.010322. J Glob Health. 2019. PMID: 31217958 Free PMC article. Review. No abstract available.